Back Pharmacopoeial Discussion Group (PDG) holds first videoconference meeting

EDQM Strasbourg, France 15/05/2018
  • Diminuer la taille du texte
  • Augmenter la taille du texte
  • Imprimer la page
  • Imprimer en PDF

The Pharmacopoeial Discussion Group (PDG), consisting of representatives from the European Pharmacopoeia (Ph.Eur.), Japanese Pharmacopoeia (JP), the United States Pharmacopoeia (USP) and the WHO (International Pharmacopoeia) as observer, held its first interim videoconference on Wednesday 11 April 2018.

As indicated in the meeting highlights of September 2017 (available here), the PDG had decided to review its meeting formats to engage more at the technical level and introduce teleconferences, as a more direct opportunity for exchanges between the experts in the regions in order to resolve issues on specific PDG topics. This resulted in changes in the format and frequency of the face-to-face meetings, which will take place once a year with one interim video conference with the purpose of the main meetings to focus more on strategic direction setting.